KRYS KRYSTAL BIOTECH INC More: the full row for KRYSTAL BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 216,979 shares; 2024Q4: 358,379 shares; 2025Q1: 441,758 shares; 2025Q2: 922,958 shares; 2025Q3: 1,018,831 shares; 2025Q4: 941,059 shares; 2026Q1: 1,153,087 shares; 2026Q2: 939,254 shares 939,254 $349M 12.03% -213,833 Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,245,387 shares; 2024Q4: 2,565,087 shares; 2025Q1: 2,574,122 shares; 2025Q2: 3,011,818 shares; 2025Q3: 1,178,860 shares; 2025Q4: 1,808,258 shares; 2026Q1: 1,284,378 shares; 2026Q2: 1,704,318 shares 1,704,318 $178M 6.14% +419,940 Timeline TGTX TG THERAPEUTICS INC More: the full row for TG THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,534,540 shares; 2024Q4: 2,681,242 shares; 2025Q1: 2,846,703 shares; 2025Q2: 2,243,935 shares; 2025Q3: 3,844,731 shares; 2025Q4: 3,139,312 shares; 2026Q1: 4,029,319 shares; 2026Q2: 2,927,895 shares 2,927,895 $161M 5.54% -1,101,424 Timeline PODD INSULET CORP More: the full row for INSULET CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 16,750 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 150,000 shares; 2026Q1: 562,500 shares; 2026Q2: 1,049,000 shares 1,049,000 $160M 5.5% +486,500 Timeline NVCR NOVOCURE LTD More: the full row for NOVOCURE LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,739,704 shares; 2025Q1: 5,521,414 shares; 2025Q2: 6,904,302 shares; 2025Q3: 9,644,872 shares; 2025Q4: 8,530,665 shares; 2026Q1: 10,492,391 shares; 2026Q2: 9,913,401 shares 9,913,401 $150M 5.18% -578,990 Timeline UTHR UNITED THERAPEUTICS CORP DEL More: the full row for UNITED THERAPEUTICS CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 101,894 shares; 2024Q4: 109,394 shares; 2025Q1: 155,394 shares; 2025Q2: 209,794 shares; 2025Q3: 150,000 shares; 2025Q4: 60,000 shares; 2026Q1: 187,187 shares; 2026Q2: 225,587 shares 225,587 $122M 4.21% +38,400 Timeline INSP INSPIRE MED SYS INC More: the full row for INSPIRE MED SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 39,000 shares; 2025Q2: 109,000 shares; 2025Q3: 728,188 shares; 2025Q4: 299,399 shares; 2026Q1: 576,299 shares; 2026Q2: 1,931,436 shares 1,931,436 $86.2M 2.97% +1,355,137 Timeline RIGL RIGEL PHARMACEUTICALS INC More: the full row for RIGEL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 934,788 shares; 2024Q4: 1,130,679 shares; 2025Q1: 1,130,679 shares; 2025Q2: 658,145 shares; 2025Q3: 330,010 shares; 2025Q4: 300,034 shares; 2026Q1: 10,000 shares; 2026Q2: 1,843,504 shares 1,843,504 $72.1M 2.49% +1,833,504 Timeline ANIP ANI PHARMACEUTICALS INC More: the full row for ANI PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 269,000 shares; 2024Q4: 205,294 shares; 2025Q1: 224,684 shares; 2025Q2: 50,743 shares; 2025Q3: 340,243 shares; 2025Q4: 486,243 shares; 2026Q1: 820,243 shares; 2026Q2: 867,760 shares 867,760 $71.8M 2.48% +47,517 Timeline BBNX BETA BIONICS INC More: the full row for BETA BIONICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,395,341 shares; 2025Q2: 3,820,158 shares; 2025Q3: 3,870,158 shares; 2025Q4: 2,534,565 shares; 2026Q1: 4,354,501 shares; 2026Q2: 4,393,714 shares 4,393,714 $68.8M 2.37% +39,213 Timeline VCEL VERICEL CORP More: the full row for VERICEL CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 80,696 shares; 2025Q1: not reported; 2025Q2: 50,953 shares; 2025Q3: 497,953 shares; 2025Q4: 764,000 shares; 2026Q1: 2,549,079 shares; 2026Q2: 1,459,152 shares 1,459,152 $64.9M 2.24% -1,089,927 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 259,398 shares; 2024Q4: 243,540 shares; 2025Q1: 1,139,740 shares; 2025Q2: 966,740 shares; 2025Q3: 859,166 shares; 2025Q4: 362,966 shares; 2026Q1: 330,517 shares; 2026Q2: 177,517 shares 177,517 $59.4M 2.05% -153,000 Timeline GERN GERON CORP More: the full row for GERON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,400,000 shares; 2025Q2: 16,140,000 shares; 2025Q3: 17,290,000 shares; 2025Q4: 23,290,000 shares; 2026Q1: 41,508,659 shares; 2026Q2: 42,808,659 shares 42,808,659 $54.8M 1.89% +1,300,000 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,322,364 shares; 2026Q1: 1,970,864 shares; 2026Q2: 1,029,252 shares 1,029,252 $53.9M 1.86% -941,612 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,162,162 shares; 2024Q4: 2,162,162 shares; 2025Q1: 2,162,162 shares; 2025Q2: 2,162,162 shares; 2025Q3: 2,162,162 shares; 2025Q4: 2,162,162 shares; 2026Q1: not reported; 2026Q2: 2,700,000 shares 2,700,000 $49.5M 1.7% new Timeline NPCE NEUROPACE INC More: the full row for NEUROPACE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,433,168 shares; 2024Q4: 2,433,168 shares; 2025Q1: 2,608,168 shares; 2025Q2: 2,312,957 shares; 2025Q3: 2,957,957 shares; 2025Q4: 2,703,208 shares; 2026Q1: 2,932,207 shares; 2026Q2: 2,911,122 shares 2,911,122 $46.3M 1.59% -21,085 Timeline PGNY PROGYNY INC More: the full row for PROGYNY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,067,000 shares; 2026Q2: 1,602,000 shares 1,602,000 $46.2M 1.59% -465,000 Timeline INDV INDIVIOR PHARMACEUTICALS INC More: the full row for INDIVIOR PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,274,000 shares; 2026Q2: 1,064,000 shares 1,064,000 $43.7M 1.5% -210,000 Timeline PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,465,070 shares 1,465,070 $40.1M 1.38% new Timeline FOCL EDAP TMS S A More: the full row for EDAP TMS S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,309,254 shares; 2024Q4: 7,309,254 shares; 2025Q1: 7,309,254 shares; 2025Q2: 7,309,254 shares; 2025Q3: 7,309,254 shares; 2025Q4: 7,309,254 shares; 2026Q1: 7,309,254 shares; 2026Q2: 7,309,254 shares 7,309,254 $37.9M 1.3% 0 Timeline GMED GLOBUS MED INC More: the full row for GLOBUS MED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 176,000 shares; 2025Q4: 887,000 shares; 2026Q1: 729,467 shares; 2026Q2: 468,922 shares 468,922 $37M 1.28% -260,545 Timeline RCUS ARCUS BIOSCIENCES INC More: the full row for ARCUS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 711,983 shares; 2026Q1: 451,983 shares; 2026Q2: 1,168,738 shares 1,168,738 $36M 1.24% +716,755 Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,090,984 shares; 2024Q4: 2,492,000 shares; 2025Q1: 816,610 shares; 2025Q2: 1,092,110 shares; 2025Q3: 2,012,110 shares; 2025Q4: 2,247,110 shares; 2026Q1: 1,726,908 shares; 2026Q2: 1,628,039 shares 1,628,039 $35.6M 1.23% -98,869 Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,065,834 shares; 2024Q4: 2,102,833 shares; 2025Q1: 2,422,833 shares; 2025Q2: 2,422,833 shares; 2025Q3: 2,422,833 shares; 2025Q4: 1,219,394 shares; 2026Q1: 938,163 shares; 2026Q2: 1,465,163 shares 1,465,163 $35.5M 1.22% +527,000 Timeline LEGN LEGEND BIOTECH CORP More: the full row for LEGEND BIOTECH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,205,000 shares 1,205,000 $34.8M 1.2% new Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 796,744 shares; 2025Q3: 796,744 shares; 2025Q4: 796,744 shares; 2026Q1: 796,744 shares; 2026Q2: 1,550,690 shares 1,550,690 $34.5M 1.19% +753,946 Timeline UNH UNITEDHEALTH GROUP INC More: the full row for UNITEDHEALTH GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 86,250 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 80,000 shares 80,000 $33.3M 1.15% new Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 441,978 shares; 2026Q1: 441,978 shares; 2026Q2: 1,654,978 shares 1,654,978 $30.6M 1.05% +1,213,000 Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,185,000 shares; 2025Q3: 679,000 shares; 2025Q4: 150,000 shares; 2026Q1: 727,000 shares; 2026Q2: 829,810 shares 829,810 $30.5M 1.05% +102,810 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 275,000 shares; 2025Q4: 408,900 shares; 2026Q1: 178,897 shares; 2026Q2: 515,279 shares 515,279 $28.4M 0.98% +336,382 Timeline PALI PALISADE BIO INC More: the full row for PALISADE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,063,687 shares 13,063,687 $27.3M 0.94% new Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 598,169 shares; 2024Q4: 814,652 shares; 2025Q1: 814,652 shares; 2025Q2: 732,968 shares; 2025Q3: 647,052 shares; 2025Q4: 702,052 shares; 2026Q1: 702,052 shares; 2026Q2: 730,907 shares 730,907 $25.3M 0.87% +28,855 Timeline ORGO ORGANOGENESIS HLDGS INC More: the full row for ORGANOGENESIS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 11,839,876 shares; 2024Q4: 12,484,876 shares; 2025Q1: 12,478,351 shares; 2025Q2: 12,343,351 shares; 2025Q3: 12,131,699 shares; 2025Q4: 9,985,951 shares; 2026Q1: 10,085,951 shares; 2026Q2: 10,140,951 shares 10,140,951 $24.6M 0.85% +55,000 Timeline SUPN SUPERNUS PHARMACEUTICALS More: the full row for SUPERNUS PHARMACEUTICALS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 520,000 shares 520,000 $24.2M 0.83% new Timeline PRCT PROCEPT BIOROBOTICS CORP More: the full row for PROCEPT BIOROBOTICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 160,000 shares; 2026Q2: 1,003,000 shares 1,003,000 $22.6M 0.78% +843,000 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 343,152 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 730,000 shares; 2025Q3: 300,000 shares; 2025Q4: 10,000 shares; 2026Q1: 450,000 shares; 2026Q2: 709,000 shares 709,000 $22.2M 0.76% +259,000 Timeline IKT INHIBIKASE THERAPEUTICS INC More: the full row for INHIBIKASE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 6,325,000 shares; 2025Q1: 6,325,000 shares; 2025Q2: 6,325,000 shares; 2025Q3: 6,325,000 shares; 2025Q4: 10,875,000 shares; 2026Q1: 10,875,000 shares; 2026Q2: 10,875,000 shares 10,875,000 $22.1M 0.76% 0 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 700,000 shares; 2025Q3: 25,000 shares; 2025Q4: 900,000 shares; 2026Q1: 1,620,000 shares; 2026Q2: 1,179,618 shares 1,179,618 $22M 0.76% -440,382 Timeline BMRN BIOMARIN PHARMACEUTICAL INC More: the full row for BIOMARIN PHARMACEUTICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,001,400 shares; 2025Q1: 1,079,304 shares; 2025Q2: 902,304 shares; 2025Q3: 890,304 shares; 2025Q4: 1,320,000 shares; 2026Q1: 650,572 shares; 2026Q2: 375,572 shares 375,572 $21.5M 0.74% -275,000 Timeline LIVN LIVANOVA PLC More: the full row for LIVANOVA PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 117,040 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 567,500 shares; 2026Q1: 582,500 shares; 2026Q2: 254,957 shares 254,957 $21M 0.72% -327,543 Timeline ARGX ARGENX SE More: the full row for ARGENX SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 28,940 shares; 2025Q2: 42,876 shares; 2025Q3: 69,426 shares; 2025Q4: 31,726 shares; 2026Q1: 3,500 shares; 2026Q2: 19,955 shares 19,955 $18.5M 0.64% +16,455 Timeline NVCT NUVECTIS PHARMA INC More: the full row for NUVECTIS PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,000,000 shares 1,000,000 $18.4M 0.63% new Timeline CAPR CAPRICOR THERAPEUTICS INC More: the full row for CAPRICOR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 646,390 shares; 2026Q1: not reported; 2026Q2: 761,737 shares 761,737 $18.3M 0.63% new Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 183,300 shares; 2025Q1: 72,300 shares; 2025Q2: 76,493 shares; 2025Q3: not reported; 2025Q4: 910,000 shares; 2026Q1: 1,449,915 shares; 2026Q2: 450,889 shares 450,889 $18.3M 0.63% -999,026 Timeline PRLD PRELUDE THERAPEUTICS INC More: the full row for PRELUDE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,378,378 shares 3,378,378 $18M 0.62% new Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 78,800 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 292,000 shares; 2026Q2: 267,000 shares 267,000 $16.1M 0.56% -25,000 Timeline CCCC C4 THERAPEUTICS INC More: the full row for C4 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,603,996 shares; 2024Q4: 6,978,942 shares; 2025Q1: 6,978,942 shares; 2025Q2: 6,978,942 shares; 2025Q3: 7,053,942 shares; 2025Q4: 3,803,942 shares; 2026Q1: 3,803,942 shares; 2026Q2: 3,377,981 shares 3,377,981 $15.8M 0.54% -425,961 Timeline KNSA KINIKSA PHARMACEUTICALS INTL More: the full row for KINIKSA PHARMACEUTICALS INTL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 302,500 shares; 2024Q4: not reported; 2025Q1: 469,500 shares; 2025Q2: 254,689 shares; 2025Q3: 150,000 shares; 2025Q4: 587,000 shares; 2026Q1: 521,353 shares; 2026Q2: 246,353 shares 246,353 $15.8M 0.54% -275,000 Timeline KIDS ORTHOPEDIATRICS CORP More: the full row for ORTHOPEDIATRICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 288,945 shares; 2024Q4: not reported; 2025Q1: 45,000 shares; 2025Q2: 45,000 shares; 2025Q3: 128,000 shares; 2025Q4: 525,447 shares; 2026Q1: 615,447 shares; 2026Q2: 732,144 shares 732,144 $14M 0.48% +116,697 Timeline AVLN AVALYN PHARMACEUTICALS INC More: the full row for AVALYN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 419,000 shares 419,000 $13.8M 0.48% new Timeline BDSX BIODESIX INC More: the full row for BIODESIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 416,599 shares; 2026Q2: 585,958 shares 585,958 $13.2M 0.46% +169,359 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 147,000 shares 147,000 $13.1M 0.45% new Timeline TWST TWIST BIOSCIENCE CORP More: the full row for TWIST BIOSCIENCE CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 354,401 shares; 2025Q3: 1,866,234 shares; 2025Q4: 1,861,802 shares; 2026Q1: 1,226,629 shares; 2026Q2: 104,629 shares 104,629 $10.8M 0.37% -1,122,000 Timeline VIR VIR BIOTECHNOLOGY INC More: the full row for VIR BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,002,000 shares; 2026Q2: 1,000,000 shares 1,000,000 $10.2M 0.35% -1,002,000 Timeline ALNY ALNYLAM PHARMACEUTICALS INC More: the full row for ALNYLAM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 59,400 shares; 2024Q4: 76,800 shares; 2025Q1: not reported; 2025Q2: 106,750 shares; 2025Q3: 15,250 shares; 2025Q4: 70,000 shares; 2026Q1: 131,650 shares; 2026Q2: 33,050 shares 33,050 $9.95M 0.34% -98,600 Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,678 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,110,000 shares; 2026Q1: 230,000 shares; 2026Q2: 252,000 shares 252,000 $9.71M 0.33% +22,000 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 30,272 shares; 2024Q4: 320,272 shares; 2025Q1: 274,272 shares; 2025Q2: 72,772 shares; 2025Q3: 2,550 shares; 2025Q4: 48,500 shares; 2026Q1: 10,250 shares; 2026Q2: 90,250 shares 90,250 $9.62M 0.33% +80,000 Timeline SEPN SEPTERNA INC More: the full row for SEPTERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 675,409 shares; 2025Q1: 751,353 shares; 2025Q2: 75,456 shares; 2025Q3: 18,260 shares; 2025Q4: 383,368 shares; 2026Q1: 275,000 shares; 2026Q2: 275,000 shares 275,000 $9.21M 0.32% 0 Timeline SOPH SOPHIA GENETICS SA More: the full row for SOPHIA GENETICS SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,850,000 shares; 2026Q2: 1,565,000 shares 1,565,000 $9.03M 0.31% -285,000 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 128,362 shares 128,362 $8.96M 0.31% new Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 298,696 shares; 2025Q3: 148,696 shares; 2025Q4: 573,614 shares; 2026Q1: 400,306 shares; 2026Q2: 75,000 shares 75,000 $8.78M 0.3% -325,306 Timeline AORT ARTIVION INC More: the full row for ARTIVION INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 388,000 shares 388,000 $8.72M 0.3% new Timeline TNDM TANDEM DIABETES CARE INC More: the full row for TANDEM DIABETES CARE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 496,039 shares; 2025Q2: 200,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 783,000 shares; 2026Q2: 575,000 shares 575,000 $8.68M 0.3% -208,000 Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 239,705 shares; 2024Q4: 75,405 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,025,000 shares; 2026Q1: 230,869 shares; 2026Q2: 165,677 shares 165,677 $8.41M 0.29% -65,192 Timeline SION SIONNA THERAPEUTICS INC More: the full row for SIONNA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 240,000 shares; 2025Q2: 376,000 shares; 2025Q3: 413,500 shares; 2025Q4: 268,500 shares; 2026Q1: 293,500 shares; 2026Q2: 177,687 shares 177,687 $7.82M 0.27% -115,813 Timeline BLTE BELITE BIO INC More: the full row for BELITE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 210,000 shares; 2025Q4: 40,354 shares; 2026Q1: not reported; 2026Q2: 50,524 shares 50,524 $7.78M 0.27% new Timeline CERS CERUS CORP More: the full row for CERUS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,000,000 shares; 2026Q1: 10,753,700 shares; 2026Q2: 2,500,000 shares 2,500,000 $7.3M 0.25% -8,253,700 Timeline SLN SILENCE THERAPEUTICS PLC More: the full row for SILENCE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 260,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 630,000 shares 630,000 $6.92M 0.24% new Timeline IMUX IMMUNIC INC More: the full row for IMMUNIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 450,000 shares 450,000 $6.92M 0.24% new Timeline IVVD INVIVYD INC More: the full row for INVIVYD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,708,727 shares; 2026Q1: 7,708,727 shares; 2026Q2: 7,708,727 shares 7,708,727 $6.73M 0.23% 0 Timeline MRK MERCK & CO INC More: the full row for MERCK & CO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 203,000 shares; 2026Q2: 50,000 shares 50,000 $6.42M 0.22% -153,000 Timeline RLMD RELMADA THERAPEUTICS INC More: the full row for RELMADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 842,106 shares; 2026Q2: 842,106 shares 842,106 $5.83M 0.2% 0 Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 90,000 shares; 2026Q1: 80,000 shares; 2026Q2: 107,000 shares 107,000 $5.74M 0.2% +27,000 Timeline EOLS EVOLUS INC More: the full row for EVOLUS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,037,680 shares; 2024Q4: 697,158 shares; 2025Q1: 1,079,158 shares; 2025Q2: 2,119,000 shares; 2025Q3: 1,450,000 shares; 2025Q4: 1,070,000 shares; 2026Q1: 2,245,360 shares; 2026Q2: 822,428 shares 822,428 $5.71M 0.2% -1,422,932 Timeline ANL ADLAI NORTYE GROUP LTD More: the full row for ADLAI NORTYE GROUP LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 405,523 shares 405,523 $4.66M 0.16% new Timeline ZNTL ZENTALIS PHARMACEUTICALS INC More: the full row for ZENTALIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 950,000 shares 950,000 $4.61M 0.16% new Timeline KPTI KARYOPHARM THERAPEUTICS INC More: the full row for KARYOPHARM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 440,000 shares; 2026Q1: 440,000 shares; 2026Q2: 440,000 shares 440,000 $4.3M 0.15% 0 Timeline CNTX CONTEXT THERAPEUTICS INC More: the full row for CONTEXT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,963,141 shares; 2026Q2: 7,063,141 shares 7,063,141 $3.91M 0.13% +100,000 Timeline LUNG PULMONX CORP More: the full row for PULMONX CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,038,323 shares; 2026Q1: 2,788,323 shares; 2026Q2: 2,788,323 shares 2,788,323 $3.62M 0.12% 0 Timeline SABS SAB BIOTHERAPEUTICS INC More: the full row for SAB BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,050,000 shares; 2026Q2: 900,000 shares 900,000 $3.51M 0.12% -150,000 Timeline TECX TECTONIC THERAPEUTIC INC More: the full row for TECTONIC THERAPEUTIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 31,841 shares; 2025Q1: 76,841 shares; 2025Q2: 76,841 shares; 2025Q3: 25,000 shares; 2025Q4: not reported; 2026Q1: 121,684 shares; 2026Q2: 101,684 shares 101,684 $3.5M 0.12% -20,000 Timeline AXGN AXOGEN INC More: the full row for AXOGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,005,943 shares; 2024Q4: 2,955,943 shares; 2025Q1: 1,446,117 shares; 2025Q2: 1,459,395 shares; 2025Q3: 1,726,553 shares; 2025Q4: 1,206,855 shares; 2026Q1: 679,170 shares; 2026Q2: 57,036 shares 57,036 $2.63M 0.09% -622,134 Timeline MSLE SATELLOS BIOSCIENCE INC More: the full row for SATELLOS BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 414,359 shares; 2026Q2: 314,359 shares 314,359 $2.44M 0.08% -100,000 Timeline AVBP ARRIVENT BIOPHARMA INC More: the full row for ARRIVENT BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares 50,000 $1.74M 0.06% new Timeline CORT CORCEPT THERAPEUTICS INC More: the full row for CORCEPT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 285,531 shares; 2026Q2: 19,653 shares 19,653 $1.71M 0.06% -265,878 Timeline SLDB SOLID BIOSCIENCES INC More: the full row for SOLID BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares 150,000 $1.5M 0.05% new Timeline VCYT VERACYTE INC More: the full row for VERACYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 54,303 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 715,439 shares; 2025Q3: 422,055 shares; 2025Q4: 10,000 shares; 2026Q1: 319,912 shares; 2026Q2: 25,000 shares 25,000 $1.47M 0.05% -294,912 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 410,200 shares; 2026Q2: 50,000 shares 50,000 $910K 0.03% -360,200 Timeline NSPR INSPIREMD INC More: the full row for INSPIREMD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,378,128 shares; 2024Q4: 1,378,128 shares; 2025Q1: 945,376 shares; 2025Q2: 1,886,207 shares; 2025Q3: 1,470,934 shares; 2025Q4: 1,150,000 shares; 2026Q1: 1,045,708 shares; 2026Q2: 1,045,708 shares 1,045,708 $732K 0.03% 0 Timeline WGS GENEDX HOLDINGS CORP More: the full row for GENEDX HOLDINGS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 4,000 shares; 2025Q1: not reported; 2025Q2: 40,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,000 shares 10,000 $686K 0.02% new Timeline IOVA IOVANCE BIOTHERAPEUTICS INC More: the full row for IOVANCE BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 8,528,500 shares; 2024Q4: 6,560,000 shares; 2025Q1: 7,785,000 shares; 2025Q2: 3,261,707 shares; 2025Q3: 976,707 shares; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 150,000 shares 150,000 $624K 0.02% -850,000 Timeline LRMR LARIMAR THERAPEUTICS INC More: the full row for LARIMAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,066,960 shares; 2026Q2: 188,102 shares 188,102 $574K 0.02% -878,858 Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 340,585 shares; 2024Q4: 328,585 shares; 2025Q1: 303,585 shares; 2025Q2: 155,000 shares; 2025Q3: 290,000 shares; 2025Q4: 170,000 shares; 2026Q1: 20,000 shares; 2026Q2: 5,000 shares 5,000 $355K 0.01% -15,000 Timeline QNRX QUOIN PHARMACEUTICALS LTD More: the full row for QUOIN PHARMACEUTICALS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,000 shares; 2026Q1: 72,730 shares; 2026Q2: 72,730 shares 72,730 $352K 0.01% 0 Timeline EQ EQUILLIUM INC More: the full row for EQUILLIUM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 90,000 shares 90,000 $288K 0.01% new Timeline NTRA NATERA INC More: the full row for NATERA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 29,900 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 119,000 shares; 2026Q2: 1,000 shares 1,000 $271K 0.01% -118,000 Timeline NEO NEOGENOMICS INC More: the full row for NEOGENOMICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 427,504 shares; 2026Q1: 175,000 shares; 2026Q2: 10,000 shares 10,000 $146K 0.01% -165,000 Timeline